All views and opinions expressed in this article are the author's own and are not endorsed by or reflective of SUCCESS. As a reader-supported publication, we may receive compensation from the products and services mentioned in this story. Learn more about how we make money and our editorial policies.
The significance of the pharmaceutical sector building public trust is an ongoing topic of discussion. For many, the consensus is that some pharmaceutical brands prioritize profits over patient wellness. Dr. William Soliman is changing this narrative and hoping to harness credibility and trust through innovation.
Based in New Jersey, Soliman is a pharmaceutical industry professional, television personality and the founder and CEO of the Accreditation Council for Medical Affairs (ACMA). The ACMA is an organization that provides data and tech solutions for medical affairs professionals and medical science liaisons (MSL) in the life sciences industry.
As a brand focused on innovation, the ACMA has a predictive analytics tool (recognized as the number one Life Sciences Exemplary Trainer in 2020) as well as an interactive, cloud-based market research application called ACMA Trends. The ACMA is most renowned for founding the Board Certified Medical Affairs Specialist (BCMAS), the first board certification in history for MSL and medical affairs professionals worldwide, which includes creating the prior authorization certification program (PACS). The ACMA’s compliance training programs also assist pharmaceutical businesses in maintaining compliance.
With numerous years of experience in medical affairs and as an MSL, Soliman has spoken to the Congressional health subcommittee about the ACMA and the importance of certification standards for medical affairs and MSL professionals in the pharmaceutical industry. He has also been invited by the U.S. Attorney General’s Alliance to discuss the ACMA and pharmaceutical industry standards.
Throughout his career, Soliman has remained passionate about patients with a solid belief that standards in the pharmaceutical industry will elevate the healthcare ecosystem. This desire to improve the industry has helped the ACMA expand its presence—currently operating in more than 80 countries.
The ACMA also has thousands of learners benefiting from the medical affairs scholarship program, which has provided more than $500,000 to those interested in pursuing careers in the pharmaceutical industry. The ACMA also established the first ever MSL/medical affairs scholarship fund at the University of Illinois Chicago College of Pharmacy.
“I have always believed in helping others grow professionally by giving them the support they need to achieve their goals,” Soliman says.
The ACMA’s mission is to continue improving standards in the pharmaceutical industry through compassionate and innovative solutions that help a variety of stakeholders in the healthcare ecosystem. The ACMA remains dedicated to helping pharmaceutical companies with their compliance training programs, a key strategy to achieving this mission.